Especially, hereditary thrombophilia, such as low levels of antithrombin, protein C, and protein S, as well as mutations in factors V and II (prothrombin) genes, are associated with thrombotic events in newborns, reflecting an imbalance between coagulants and anticoagulant activity. Here, F2 is linked to inherited thrombophilia.